Stay updated on Nivolumab for Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.

Latest updates to the Nivolumab for Prostate Cancer Clinical Trial page
- ChecktodayChange DetectedRevision: v3.4.3 added; Prostate cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.2 were removed from the page.SummaryDifference0.2%

- Check7 days agoChange DetectedAdded related topics 'Prostate cancer' and a link to 'MedlinePlus Genetics' to the page navigation.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.4.2 was added, and the funding-lapse notice along with the prior Revision: v3.4.1 entry were removed.SummaryDifference0.4%

- Check36 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1; there are no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedThe changes are minor UI and metadata updates (Show glossary option; the label 'Last Update Submitted that Met QC Criteria'; capitalization adjustments; and a new revision version to v3.4.0) that do not alter core study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check57 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the page footer, with no changes to study details or core content; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.